Inventor · disambiguated record
John Emmerson Campbell
Also filed as: CAMPBELL JOHN · CAMPBELL JOHN E · CAMPBELL JOHN EMMERSON
44 granted patents·37 pending applications·299 citations·filing 1998–2024
98Inventor score
Files withEPIZYME INC44SUNOVION PHARMACEUTICALS INC17BLUEPRINT MEDICINES CORP8CAMPBELL JOHN EMMERSON2SHAO LIMING2
Top patents by PatentIndex Score
81 records- 0198US9532992B2Substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Jan 3, 2017·32 cites·25 claims
- 0297US9089575B2Substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Jul 28, 2015·19 cites·16 claims
- 0397US9045477B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2014·Granted Jun 2, 2015·19 cites·17 claims
- 0497US9006242B2Substituted benzene compoundsEPIZYME INC·Filed 2013·Granted Apr 14, 2015·38 cites·18 claims
- 0596US11642348B2Substituted benzene compoundsEPIZYME INC·Filed 2020·Granted May 9, 2023·4 cites·12 claims
- 0695US10894033B2Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Jan 19, 2021·3 cites·21 claims
- 0795US9776996B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2014·Granted Oct 3, 2017·13 cites·17 claims
- 0895US9701666B21,4-pyridone bicyclic heteroaryl compoundsEPIZYME INC·Filed 2013·Granted Jul 11, 2017·14 cites·18 claims
- 0995US9624205B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2014·Granted Apr 18, 2017·15 cites·16 claims
- 1095US8710245B2Multicyclic compounds and methods of use thereofSHAO LIMING·Filed 2010·Granted Apr 29, 2014·32 cites·41 claims
- 1194US9243001B2Substituted benzene compoundsEPIZYME INC·Filed 2014·Granted Jan 26, 2016·10 cites·4 claims
- 1293US11718602B2EGFR inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Granted Aug 8, 2023·2 cites·8 claims
- 1393US10098888B2Substituted benzene compoundsEPIZYME INC·Filed 2016·Granted Oct 16, 2018·8 cites·16 claims
- 1493US9365570B2Substituted 6, 5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2015·Granted Jun 14, 2016·6 cites·7 claims
- 1592US10150759B21,4-pyridone bicycic heteroaryl compoundsEPIZYME INC·Filed 2017·Granted Dec 11, 2018·6 cites·20 claims
- 1691US10085968B2Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2015·Granted Oct 2, 2018·7 cites·60 claims
- 1791US9351954B2Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted May 31, 2016·10 cites·37 claims
- 1890US11672800B2Combination therapies with EHMT2 inhibitorsEPIZYME INC·Filed 2018·Granted Jun 13, 2023·5 cites·20 claims
- 1990US10174019B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2016·Granted Jan 8, 2019·4 cites·20 claims
- 2088US10092572B2Substituted benzene compoundsEPIZYME INC·Filed 2013·Granted Oct 9, 2018·8 cites·31 claims
- 2187US10150764B2Substituted benzene compoundsEPIZYME INC·Filed 2014·Granted Dec 11, 2018·5 cites·19 claims
- 2287US9249162B2Substituted [1,2,4]triazolo[1,5-a]pyridines as PDE-10 inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted Feb 2, 2016·7 cites·27 claims
- 2386US10562916B2Substituted quinoxalines as PDE-10 inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 18, 2020·4 cites·24 claims
- 2486US8969349B2Substituted quinoxalines and quinoxalinones as PDE-10 inhibitorsCAMPBELL JOHN EMMERSON·Filed 2011·Granted Mar 3, 2015·10 cites·25 claims
- 2585US2024358675A1Multicyclic compounds and methods of use thereofSUMITOMO PHARMA AMERICA INC·Filed 2024·Application pending·0 cites
- 2684US2024165121A1Substituted benzene compoundsEPIZYME INC·Filed 2023·Application pending·0 cites
- 2781US10556890B2Heteroaryl compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 11, 2020·2 cites·14 claims
- 2880US2022387382A1Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2980US2025289801A1Egfr inhibitorsBLUEPRINT MEDICINES CORP·Filed 2024·Application pending·0 cites
- 3078US8765760B2[1,2,4] triazol [1,5-a] pyrazines useful as inhibitors of phosphodiesterasesCAMPBELL JOHN EMMERSON·Filed 2012·Granted Jul 1, 2014·3 cites·22 claims
- 3176US12116358B2Substituted indoles and methods of use thereofEPIZYME INC·Filed 2019·Granted Oct 15, 2024·1 cites·70 claims
- 3275US10189825B2Heteroaryl compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2013·Granted Jan 29, 2019·2 cites·25 claims
- 3375US2021267938A1Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3472US12172983B2EGFR inhibitorsBLUEPRINT MEDICINES CORP·Filed 2021·Granted Dec 24, 2024·0 cites·21 claims
- 3572US2023357208A1Myst family histone acetyltransferase inhibitorsEPIZYME INC·Filed 2023·Application pending·0 cites
- 3670US11332462B2Heteroaryl compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2019·Granted May 17, 2022·0 cites·15 claims
- 3770US6419939B2Compound for the amelioration of pseudofolliculitisFiled 2001·Granted Jul 16, 2002·1 cites·6 claims
- 3869US9994590B2Substituted [1,2,4]triazolo[1,5-a]pyrazines as phosphodiesterase inhibitorsSUNOVION PHARAMACEUTICALS INC·Filed 2016·Granted Jun 12, 2018·1 cites·25 claims
- 3969US8877975B2Cycloalkylamines as monoamine reuptake inhibitorsSHAO LIMING·Filed 2010·Granted Nov 4, 2014·1 cites·23 claims
- 4069US6989152B1Compound for the amelioration of pseudofolliculitisCAMPBELL JOHN·Filed 2003·Granted Jan 24, 2006·1 cites·4 claims
- 4168US2019125722A1Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4268US2022274961A1Substituted fused bi- or tri- heterocyclic compounds as ehmt2 inhibitorsEPIZYME INC·Filed 2021·Application pending·0 cites
- 4367US2022324851A1Amine-substituted heterocyclic compounds as ehmt2 inhibitors, salts thereof, and methods of synthesis thereofEPIZYME INC·Filed 2022·Application pending·0 cites
- 4467US2023364086A1Combination therapies with ehmt2 inhibitorsEPIZYME INC·Filed 2023·Application pending·0 cites
- 4567US2022235065A1Amine-substituted heterocyclic compounds as ehmt2 inhibitors and methods of use thereofEPIZYME INC·Filed 2021·Application pending·0 cites
- 4666US2019060322A1Substituted benzene compoundsEPIZYME INC·Filed 2018·Application pending·0 cites
- 4765US9868718B2Cycloalkylamines as monoamine reuptake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted Jan 16, 2018·0 cites·2 claims
- 4862US2025236608A1Egfr inhibitorsBLUEPRINT MEDICINES CORP·Filed 2023·Application pending·0 cites
- 4961US10570156B2Substituted imidazo[1,2-a]pyridines as PDE-10 inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 25, 2020·0 cites·18 claims
- 5061US2023087806A1Methods of using ehmt2 inhibitorsEPIZYME INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 81 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John Emmerson Campbell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →